万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发,品质稳、品类全,实验不再等!Takara 秋促来袭,提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ¥1200阿拉丁 22万+ 科研级产品现货速发,品质严控、科研无忧- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 英文名:
Seracare
- 供应商:
美国Seracare
美国Seracare传染病阳性血清转换盘(120种血清盘)
广州健仑生物科技有限公司
SeraCare Life Sciences公司主要在美国、欧洲和亚洲提供促进人类和动物诊断和治疗学的探索、开发和生产的产品和服务。其业务分为两个部分:诊断和生物制药产品和生物服务。诊断和生物制药产品部门生产和销售诊断和控制面板产品,用于测试传染性疾病的临床实验室及员工培训和能力测试。生物服务部门提供生物银行、来样加工和测试服务。
美国SeraCare收购BBI公司,即原BBI血清盘已经改名为SeraCare血清盘。
其产品包括有:传染病阳性质控品、疾病标准品、细菌阳性质控品、人血清白蛋白、人伽马球蛋白、牛血清白蛋白、血清盘、人血浆、人血清。
SeraCare的血清盘包括:HIV-1转化盘、HIV性能盘、HBV转化盘、HBV性能盘、HCV转化盘、HCV性能盘、弓形虫性能盘、线性盘和质控盘等等。
我司还提供其它进口或国产试剂盒:登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品欢迎致电。
欢迎电话咨询13802525278
欢迎QQ咨询2042552662
美国Seracare传染病阳性血清转换盘(120种血清盘)
| 产品货号 | 产品英文名称 | 产品名称及简介 |
| JL-SC001 | HIV-1 Seroconversion Panels | HIV-1转化盘 |
| JL-SC002 | HIV 1 SC Pnl N | HIV 1血清阴转盘 |
| JL-SC003 | HIV 1 SC Pnl AU | 阳性:HIV RNA 阴转阳:HIV Ag (p24),anti-HIV-1 |
| JL-SC004 | HIV 1 SC Pnl AV | 阳性:HIV RNA,HIV Ag (p24) 阴性:anti-HIV-1 |
| JL-SC005 | HIV-1 SC Pnl | 阳性:HIV RNA,HIV Ag (p24) 阴转阳:anti-HIV-1 |
| JL-SC006 | HIV 1 SC Pnl AY Modified | 阳性:HIV RNA,HIV Ag (p24),anti-HIV-1 |
| JL-SC007 | HIV 1 SC Pnl AZ | 阳性:HIV RNA,HIV Ag (p24) 阴转阳:anti-HIV-1 |
| JL-SC008 | HIV 1 SC Pnl BC | 阳性:HIV-1 RNA 阴转阳:HIV抗体,抗原 |
| JL-SC009 | HIV 1 SC Pnl BD | 阴转阳:HIV抗体,p24抗原,HIV-1 RNA |
| JL-SC010 | HIV 1 SC Pnl BE | 阳性:HIV RNA 阴转阳:HIV Ag (p24),anti-HIV-1 |
| JL-SC011 | HIV 1 SC Pnl BF | 阴转阳:HIV RNA,HIV Ag (p24),anti-HIV-1 |
| JL-SC012 | HIV 1 SC Pnl | 阴转阳:HIV RNA,HIV Ag (p24) 阴性:anti-HIV-1 |
| JL-SC013 | HIV 1 SC Pnl | 阴转阳:HIV RNA,HIV Ag (p24) 阴性:anti-HIV-1 |
| JL-SC014 | HIV 1 SC Pnl | 阴转阳:HIV RNA,HIV Ag (p24) 阴性:anti-HIV-1 |
| JL-SC015 | HIV 1 SC Pnl | 感染期间血浆 |
| JL-SC016 | HIV 1 SC Pnl | 感染期间血浆 |
| JL-SC017 | HIV 1 SCPnl | 阴转阳:HIV(RNA、抗原、抗原抗体、抗体) 阴性:HBsAg,anti-HCV |
| JL-SC018 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC019 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC020 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC021 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC022 | HIV 1 SC Pnl | 阳性:HIV RNA |
| JL-SC023 | HIV 1 SC Pnl 4 x 1.2 mL | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC024 | HIV 1 SC Pnl 4 x 1.2 mL | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC025 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC026 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC027 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC028 | HIV 1 SC Pnl | 阳性:HIV-1 RNA,HIV-1 Ag,anti-HIV 阴性:anti-HCV,HBsAg |
| JL-SC029 | HIV Performance Panels | HIV性能盘 |
| JL-SC030 | HIV Worldwide Performance Panel | HIV全球性能盘(包含9种基因型) |
| JL-SC031 | HIV-1 Incidence Prevalence Performance Panel | HIV-1新感染性能盘 |
| JL-SC032 | HIV-1 Genotype Performance Panel | HIV-1基因型性能盘 |
| JL-SC033 | HIV RNA Genotype Pnl | HIV RNA基因型性能盘 |
| JL-SC034 | HIV Drug Resistance Pnl Teragenix HIVDRP | HIV耐药性能盘(Teragenix HIVDRP) |
| JL-SC035 | HIV 1 group O Perf Panel | HIV-1组O性能盘 |
| JL-SC036 | HIV Early Inf Perf Pnl | HIV早期感染性能盘 |
| JL-SC037 | HIV p24 Ag MT Perf Pnl Mod PRA204(M) | HIV p24抗原多价性能盘 |
| JL-SC038 | Anti-HIV 1 LT Perf Pnl Mod PRB109(M) | 抗HIV-1低价性能盘 |
| JL-SC039 | Anti-HIV 1 MT Perf Pnl Mod PRB205(M2) | 抗HIV-1多价性能盘 |
| JL-SC040 | HIV-1 RNA EDTA Perf Pnl | HIV-1 RNA EDTA性能盘 |
| JL-SC041 | HIV-1/2 MT Perf Pnl | HIV-1/2多价性能盘 |
| JL-SC042 | HIV-2 MT Perf Pnl | HIV-2多价性能盘 |
| JL-SC043 | HBV Seroconversion Panels | HBV转化盘 |
| JL-SC044 | HBV SC Pnl | 阴转阳:HBV DNA,HBsAg 阴性:HBeAg,anti-HBc IgM,anti-HBc Total,anti-HBe,anti-HBs |
| JL-SC045 | HBV SC Pnl | 乙肝血清阳转盘 |
| JL-SC046 | HBV SC Pnl | 阴转阳:HBV DNA,HBsAg |
| JL-SC047 | HBV SC Pnl | 感染期间单个患者血浆 |
| JL-SC048 | HBV SC Pnl 5 x 1.5 mL | 阳性:HBV DNA 其它HBV标记物都是阴性 |
| JL-SC049 | HBV SC Pnl 5 member panel | 阳性:HBV DNA 其它HBV标记物很早就预期是阳性 |
| JL-SC050 | HBV SC Pnl | 阴转阳:HBsAg 阳性:HBV DNA 阴性:HBV抗体 |
| JL-SC051 | HBV SC Pnl | |
| JL-SC052 | HBV Performance Panels | HBV性能盘 |
| JL-SC053 | HBc IgM MT Pnl Mod PHE203(M) | 阴转阳:HBc IgM |
| JL-SC054 | HBsAg MT Perf Pnl Mod PHA207(M) | |
| JL-SC055 | Anti-HBc/Anti-HBs MT Perf Pnl | 阴转阳:anti-HBc,anti-HBs |
| JL-SC056 | HBV WW Perf Pnl | |
| JL-SC057 | HBsAg LT Perf Pnl Mod PHA107(M) | 乙肝表面抗原低价性能盘 |
| JL-SC058 | HCV Seroconversion Panels | HCV转化盘 |
| JL-SC059 | HCV SC Pnl | 阴转阳:anti-HCV EIA 阳性:HCV RNA 阴性:anti-HCV RIBA |
| JL-SC060 | HCV SC Pnl | 变量转换:anti-HCV EIA 阳性:HCV RNA 阴性:anti-HCV RIBA |
| JL-SC061 | HCV SC Pnl | 阴转阳:HCV RNA,anti-HCV RIBA 变量转换:anti-HCV EIA |
| JL-SC062 | HCV SC Pnl | 阴转阳:HCV RNA,anti-HCV RIBA,anti-HCV EIA |
| JL-SC063 | HCV SC Pnl Modified | 阴转阳:anti-HCV EIA,HCV基因型1a 阳性:HCV RNA |
| JL-SC064 | HCV SC Pnl | 阴转阳:anti-HCV EIA,HCV基因型3a 阳性:HCV RNA |
| JL-SC065 | HCV SC Pnl | 阳性:anti-HCV,HCV RNA 阴性:anti-HIV,HBsAg |
| JL-SC066 | HCV SC Pnl | 阳性:anti-HCV,HCV RNA 阴性:anti-HIV,HBsAg |
| JL-SC067 | HCV SC Pnl | 阳性:anti-HCV,HCV RNA 阴性:anti-HIV,HBsAg |
| JL-SC068 | HCV SC Pnl | 阴转阳:HCV RNA 阴性:anti-HCV(早期感染) |
| JL-SC069 | HCV SC Pnl | 阴转阳:HCV RNA 阴性:anti-HCV(早期感染) |
| JL-SC070 | HCV SC Pnl | 阴转阳:HCV RNA 阴性:anti-HCV(早期感染) |
| JL-SC071 | HCV Performance Panels | HCV性能盘 |
| JL-SC072 | HCV MT Perf Pnl | anti-HCV多价性能盘 |
| JL-SC073 | HCV LT Perf Pnl | anti-HCV低价性能盘 |
| JL-SC074 | Other Seroconversion Panels | 其它的转化盘 |
| JL-SC075 | Syphilis SC panel | 梅毒血清转化盘 |
| JL-SC076 | HAV SC Pnl | HAV血清转化盘 阳转阴:HAV RNA 阴转阳:anti‑HAV IgM,anti‑HAV Total |
| JL-SC077 | HAV SC Pnl | HAV血清转化盘 阳性:HAV RNA 阴转阳:HAV抗体 |
| JL-SC078 | Chagas SC Pnl | 南美锥虫病血清转化盘 |
| JL-SC079 | CMV Seroconversion Panel | 巨细胞病毒血清转化盘 |
| JL-SC080 | WNV SC Pnl | 西尼罗河病毒血清转化盘 阴转阳:WNV RNA,anti-WNV Total,anti-WNV IgM |
| JL-SC081 | ToRCH Performance Panels | 弓形虫性能盘 |
| JL-SC082 | Anti-HSV 1/2 MT Perf Pnl | 抗HSV 1/2多价性能盘 |
| JL-SC083 | Toxo MT Perf Pnl 21 Member Panel | 弓形虫混合性能盘 阳性:IgG抗体 |
| JL-SC084 | Exotic/Insect-Borne Performance Panels | 外来虫媒性能盘 |
| JL-SC085 | Dengue MT Perf Pnl | 登革热混合性能盘 阴转阳:IgG/IgM抗体 |
| JL-SC086 | Chagas Mixed Titer Performance Panel | 南美锥虫病多价性能盘 |
| JL-SC087 | Other Performance Panels | 其它的性能盘 |
| JL-SC088 | Anti-EBV MT Perf Pnl 21 Member Panel | 抗EB病毒多价性能盘 |
| JL-SC089 | HTLV I/II MT Perf Pnl | 人类嗜T细胞病毒I/II型多价性能盘 |
| JL-SC090 | CMV MT Perf Pnl | 巨细胞病毒多价性能盘 |
| JL-SC091 | Anti-HAV MT Perf Pnl | 抗甲肝多价性能盘 |
| JL-SC092 | Parvo B19 MT Perf Pnl | 细小病毒B19多价性能盘 阴转阳:B19 DNA,IgM/IgG抗体 |
| JL-SC093 | Syphilis AccuSet Perf Pnl | 梅毒性能盘 |
| JL-SC094 | Linearity Panels | 线性盘 |
| JL-SC095 | HBsAg Sensitivity Panel | 乙肝表面抗原线性盘 |
| JL-SC096 | HBV DNA Linearity Panel | 乙肝DNA线性盘 |
| JL-SC097 | HCV RNA Linearity Panel | 丙肝RNA线性盘 |
| JL-SC098 | CMV DNA Linearity Panel | 巨细胞DNA线性盘 |
| JL-SC099 | HIV-1 RNA Linearity Panel 1.2 mL | HIV-1 RNA线性盘 |
| JL-SC100 | BK Virus Linearity Panel | BK病毒线性盘(1瓶强阳性、1瓶中阳性、1瓶弱阳性、1瓶阴性) |
| JL-SC101 | AccuSpan EBV Lin Pnl 4 x 1 mL | EB病毒线性盘 |
| JL-SC102 | AccuSpan HSV-1 Lin Pnl 4 x 1 m | 单纯疱疹病毒1型线性盘 |
| JL-SC103 | AccuSpan HSV-2 Lin Pnl 4 x 1 m | 单纯疱疹病毒2型线性盘 |
| JL-SC104 | JC Virus (JCV) Linearity Panel | JC病毒线性盘 |
| JL-SC105 | VZV Linearity Panel | 水痘带状疱疹病毒线性盘 |
| JL-SC106 | Adenovirus Linearity Panel | 腺病毒线性盘 |
| JL-SC107 | Qualification Panels | 质控盘 |
| JL-SC108 | HIV RNA/HCV RNA/HBV DNA Qualification Panel | HIV RNA/HCV RNA/HBV DNA质控盘 |
| JL-SC109 | HBsAg Qualification Panel | 乙肝表面抗原质控盘 |
| JL-SC110 | Anti-HBc Qualification Panel | 抗HBc质控盘 |
| JL-SC111 | HCV Ab Qualification Panel TQS | 丙肝抗体质控盘 |
| JL-SC112 | HIV 1/2/O/p24 Qualification Panel | HIV 1/2/O/p24质控盘 |
| JL-SC113 | Anti-HIV 1/2 Qualification Panel | 抗HIV 1/2质控盘 |
| JL-SC114 | HPV DNA Genotype Qualification Panel | HPV DNA基因型质控盘 |
| JL-SC115 | Syphilis Qualification Panel | 梅毒质控盘 |
| JL-SC116 | Anti-CMV Qualification Panel | 抗CMV质控盘 |
| JL-SC117 | Anti-HTLV I/II Qualification Panel | 抗HTLV I/II质控盘 |
| JL-SC118 | HCV RNA Genotype Accutrak Qual Panel | HCV RNA基因型质控盘 |
| JL-SC119 | CMV DNA Accutrak Qual Panel | 巨细胞DNA质控盘 |
美国Seracare传染病阳性血清转换盘(120种血清盘)
想了解更多的产品及服务请扫描下方二维码:

【公司名称】 广州健仑生物科技有限公司
【市 场 部】 13802525278 020-82574011 杨永汉
【公司传真】 020-32206070
【腾讯Q Q】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室


来自CG公司(Complete genomics)、Reprogenetics公司以及纽约大学生殖中心(NYU Fertility Center)的科学家开发出一种新的“全基因组测序”的方法,或许可以解决这一难题。他们从刚刚接受体外受精的试管胚胎中提取5到10个细胞组织,进行扫描,分析其可能存在的不利突变。这项研究2月11日在线发表在Genome Research上。
首先,研究者从2个IVF胚胎中挑选的3个活体细胞组织进行基因测序以寻找新生突变,发现精子和卵子的突变并不完全继承父母双亲的基因。那些自发的突变常常会引起先天性混乱,例如自闭症、癫痫以及一些严重的智力问题。
CG公司的首席科学家Radoje Drmanac博士和领衔这项研究、文章的共同作者Brock Peters则认为:由于每个个体基因引起的新生突变平均小于100个,而要检出父母双方的原始突变,这能够导致许多类型的疾病,需要极低的错误率。
过去从胚胎的囊胚中提取5到10个细胞活体组织,在进行测序前,DNA先被扩增。由于缺乏复制的保真度,扩增过程将产生成千上万个错误,其中很多错误将会导致连续的突变,并产生假阳性结果。现在的方法,是利用长片段的读取技术,可以消除100,000个测序错误,若是用于临床上,将会减少100个错误折叠。
根据文章所述,科学家能够检测出IVF胚胎中82%的新生突变。有意思的是,他们在一个胚胎中的蛋白编码区域找不到任何突变,而来自同一夫妇的另一个胚胎则出现了2个编码突变,分别是ZNF266和SLC26a10基因,这些基因的突变导致了很严重的疾病或遗传缺陷。然而科学家目前还不清楚他们所观察到的特殊突变是否会导致胎儿的其他健康风险。Drmanac教授和Peters教授补充道:现在最大的问题是怎样分析这些突变对医学的影响,并基于这些结果做出何种决定。
此外,科学家认为全基因组测序技术(WGS)对试管婴儿(IVF)的另一好处是可以用于难以获得细胞的临床应用,譬如肿瘤循环细胞及胎儿循环细胞。
随着测序技术的发展,宏基因组学逐渐成为了新的热门领域。宏基因组学主要是鉴定环境样本中的所有微生物,理解它们各自所起的作用。这类研究比一般的基因组分析更需要计算机技术的帮助,因为宏基因组学研究的是不同基因组的混合物。
Scientists from Complete Genomics, Reprogenetics, and the NYU Fertility Center have developed a new "genome-wide sequencing" approach that may solve this problem. They extracted 5 to 10 cell tissues from in vitro fertilized test-tube embryos and scanned them for possible adverse mutations. The study was published online at Genome Research on February 11th.
First, the researchers performed genetic sequencing on three live cell tissues selected from two IVF embryos to search for new mutations. It was found that mutations in sperm and eggs did not completely inherit the genes of both parental parents. Those spontaneous mutations often cause congenital disorders such as autism, epilepsy, and some serious intellectual problems.
Dr. Radoje Drmanac, chief scientist of CG Corporation, and led the study, co-author Brock Peters, believes that because each individual gene causes fewer than 100 new mutations on average, it is necessary to detect the original mutations of both parents, which can lead to Many types of diseases require extremely low error rates.
In the past, 5 to 10 cells of living tissue were extracted from embryonic blastocysts and the DNA was first amplified before sequencing. Due to the lack of replication fidelity, the amplification process will generate thousands of errors, many of which will lead to continuous mutations and false positive results. The current method is to use long-range reading technology, which can eliminate 100,000 sequencing errors. If it is used clinically, it will reduce 100 misfoldings.
According to the article, scientists were able to detect 82% of newborn mutations in IVF embryos. Interestingly, they could not find any mutations in the protein coding region of one embryo, while two embryos from the same couple had two coding mutations, the ZNF266 and SLC26a10 genes, and the mutations in these genes caused serious mutations. The disease or genetic defect. However, scientists are still unclear whether the specific mutations they observe will cause other health risks to the fetus. Prof. Drmanac and Professor Peter added: The biggest question now is how to analyze the impact of these mutations on medicine, and based on these results What kind of decision.
In addition, scientists believe that another benefit of whole genome sequencing (WGS) for IVF is that it can be used in clinical applications where it is difficult to obtain cells, such as tumor circulating cells and fetal circulating cells.
With the development of sequencing technology, metagenomics has gradually become a new hot area. Metagenomics is mainly to identify all microorganisms in an environmental sample and understand their respective roles. This type of research requires more computer technology than generic genomics because metagenomics studies a mixture of different genomes.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
询价记录
暂无询价记录
文献和实验临床考核血清盘的建议 以抗-HBc-IgM为例,部临检中心收集近百例临床肝炎病人的样本,经美国abbott公司抗-HBc-IgM试剂反复检验筛选。选出血清70份,其中阳性29份,阴性41份,组成抗-HBc-IgM临床考核血清盘。在70份样本中,除7份为无病历的质控血清外,抗-HBc-IgM阳性的22份样本中含临床诊断急性肝炎16例、慢性活动性肝炎5例、重症肝炎1例;抗-HBc-IgM阴性的40份样本中,含临床诊断慢性迁延性肝炎24例、急性肝炎例(均为恢复期采的血样)、慢性活动性肝炎8例(其中5例
一半;5、 阳性样本中,应有一定数量的强阳性和弱阳性样本;6、 血清盘中应有一定数量的临界值上、下含量的样品,以检验试剂的灵敏度。7、 血清盘中应包含与该项检验相关的病种样本和已积知具有干扰物质(RF因子)的样本,以检验试剂的特异性。6.3 临床考核血清盘的建议以抗-HBc-IgM为例,部临检中心收集近百例临床肝炎病人的样本,经美国abbott公司抗-HBc-IgM试剂反复检验筛选。选出血清70份,其中阳性29份,阴性41份,组成抗-HBc-IgM临床考核血清盘。在70份样本中,除7份为无病
技术资料暂无技术资料 索取技术资料










